| Company/Division name | Noven Pharmaceuticals |
| Parent company | Hisamitsu Pharmaceutical Co |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 10 |
| Year reshoring announced: | 2024 |
| Year reshoring implemented or to be implemented: | 2034 |
| Capital investment ($): | 40 |
| Country(ies) from which reshored: | Japan |
| City reshored to: | Kendall |
| State(s) reshored to: | FL |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharma |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Impact on domestic economy, Manufacturing/engineering joint innovation (R&D) |
